William Sheridan

BioCryst Pharmaceuticals (United States)

Also affiliated with Kaiser Permanente Redwood City Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial”.

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Journal of Allergy and Clinical Immunology(2020)10.1016/j.jaci.2020.10.015

N/A

5.2DataRank · unranked

164 citations

William R. Lumry, Douglas Johnston, Emel Aygören‐Pürsün, Aleena Banerji, Jonathan A. Bernstein +31 more

Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.03.057

N/A

1.9DataRank · unranked

63 citations

Emel Aygören‐Pürsün, Jonathan A. Bernstein, Timothy Craig, Richard Gower, Joshua Jacobs +11 more

A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques

Science Translational Medicine(2020)10.1126/scitranslmed.aau9135

N/A

0DataRank · unranked

26 citations

Christa E. Osuna, Katharine Best, Ray Taylor, Elsa Chen, Gyeol Yoon +13 more